Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V} -- Ignore unavailable to you. Want to Upgrade?

To: CPAMarty who wrote (88)	2/24/1999 8:21:00 AM
From: BRAVEHEART	Read Replies (1) \| Respond to of 423

Hi Marty, 1. I have been trying to free up some cash for IMCL. The stock has considerable resistance between $8 & $9.5. I plan on getting in and hoping to ride it to $12 to $15...Then evaluating it again based on an artificial time line construct. clearstation.com The signals are good close to $9 IMHO. 2. Anyone following MEDX...I posted awhile back on it but have not had time to profile it. I need someones input on the companies science. I like it in every other respect. I am assuming it is a good play assuming they can resolve the buffer conflict with the P-3 trial. I have targeted MEDX for three buys close to three...If it falls through three soon I look to buy the second and third installments. If it doesn't and accumulation continues then I will buy in above/near three if possible. The recent volume may be related to the Q-report. Lower loss always attracts a few waiting in the wings. I am hoping the short term profit takers bring it back to my target level. The signals are suggesting a trend up...will it be a long term sustained trend...let's hope so...Nothing expected to suggest at this point that it would break $4.5...Incresed sustained volume would suggest otherwise...Recent interest may not be enough to signal a trend... clearstation.com 3. I consider LXR a clear T/A speculative trend play through May...The first time I targeted it in Dec it traded from $1 to $1.75...Then it hit a buck..I then posted it here at $1.25 once I started this thread...It proceded to $1.75 again...Formed a double top...Returned to a buck ( Post Conference call...which rarely attracts new buyers but occasionally produces sellers when they realize the risks associated with their investments ). There was a lot of stock offered around a buck..We could see a short suckers rally absent news..I believe there is significant support resistance at 7/8ths it may be worth the speculative play looking for some sort of science/future product related news. May clearly is the most risky point to hold the stock near term because toxicity results for Elerix become available. The signals are not confirming of a trend up. I believe they would fail to confirm until $1.25...25% later. To me the downside appears to be less at this point. clearstation.com The above are only attempts at considering the rough T/A of a few stocks prospective entry points. Clearly exit points come a lot faster with biotech and one should clearly follow T/A from an entry point perspective through a decision to exit. Certainly short term gains of 33%, 50%, or 100%+ or better need to be emphasized in light of a decision to hold through a period with overbought conditions or hyped speculative interest. Clearly those Biotech stocks which most often manage sustained breakouts are almost always product related IMNX etc... PS: Mike I know you were looking at GLGC...I have followed GLGC since it's IPO...It fell out of favior about the same time of the market crash. There was a lot of uncertainity related to it's acquisition. I too was concerned at that time with the issue of increased burn with the acquisition. I learned at three that the burn would be affected little. Lucky me. clearstation.com Anyway. In a healthy market post IPO the stock trended down to resistance points of $6 and $7...The question is will profit taking on a down trend break $6. I am of the thought that absent sig news and given current market trends with biotech in general for those that have ralled up post crash...it will break below $6. I will start to follow it again from a technical perspective if it does. BEST WISHES Jeffrey